Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Cadrenal Therapeutics Inc CVKD

Healthcare Biotechnology
Cadrenal Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on developing tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (ESRD), and atrial fibrillation (irregular heartbeat) (AFib). The Company’s lead drug candidate, tecarfarin, is an... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:CVKD)

Cadrenal Therapeutics Named Anticoagulation Therapy Company of the Year by Pharma Tech Outlook

PR Newswire 5 days ago

CADRENAL THERAPEUTICS HIGHLIGHTS PRESENTATION AT EUROPEAN ASSOCIATION FOR CARDIO-THORACIC SURGERY (EACTS) MEDICAL CONGRESS

PR Newswire 12 days ago

CADRENAL THERAPEUTICS PROVIDES THIRD-QUARTER CORPORATE UPDATE

PR Newswire November 7, 2024

Cadrenal Therapeutics Announces Exercise of Warrants for $4.7 Million Gross Proceeds

PR Newswire November 1, 2024

Cadrenal Therapeutics Raises $5.1 Million via At-The-Market Facility

PR Newswire October 24, 2024

CADRENAL THERAPEUTICS JOINS CORPORATE COUNCIL OF ANTICOAGULATION FORUM

PR Newswire October 23, 2024

Cadrenal Therapeutics to Participate in Lytham Partners Fall 2024 Investor Conference

PR Newswire September 23, 2024

Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing

Accesswire September 11, 2024

Cadrenal Therapeutics Announces Upcoming Type-B FDA Meeting in September to Discuss Tecarfarin Trial in LVAD Patients

PR Newswire August 22, 2024
View More News ››

Opinion & Analysis (NDAQ:CVKD)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:CVKD)

CVKD.....My take ....FWIW

This up-coming meeting with FDA could prov to be a major catalyst Caution is needed This has to hold ~ $9.20 or I will say somebody...
Iseneschal - September 13, 2024

CVKD....LoL my timing is impeccable....R u watching the dip?

now at $10.05 and Green to Red move Cheers !
Iseneschal - September 13, 2024

CVKD,,,,$12.00 Holla !!!!

Low volume runner.....I'm out ; ) Sold to America
Iseneschal - September 13, 2024

CVKD......I call this daily action "Walkin the Dog"

Now over $11 which is the highest price since the recent Reverse Split....just sayin Up coming meeting with FDA
Iseneschal - September 13, 2024

Type B FDA Meeting....FYI

What are Type B FDA meetings?     ...
Iseneschal - August 22, 2024

RE:CVKD....I hope u all realize this is going to rip to......

Read the previous post which has the todays News Release. Cheers !
Iseneschal - August 22, 2024
View more Bullboard ››

Sparta Capital Ltd.

Sparta Capital Ltd.

Sparta Capital Ltd. is a technology-based company. The Company is focused on integrating emerging technologies. The Company ...
View More »